This approach is based on the fact that infiltrated NK cells within the tumor make contact, via CD9 and CD103, with αv integrin on GSCs; this cell contact mediates the release of TGF-β1 by GSCs, which in turn suppresses the cytotoxic function of NK cells [157]. The gene discussed is TGFB1; the disease is neoplasm.